Royce & Associates LP Insmed Inc Transaction History
Royce & Associates LP
- $9.35 Billion
- Q3 2025
A detailed history of Royce & Associates LP transactions in Insmed Inc stock. As of the latest transaction made, Royce & Associates LP holds 92,376 shares of INSM stock, worth $17.8 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
92,376
Previous 90,027
2.61%
Holding current value
$17.8 Million
Previous $9.06 Million
46.83%
% of portfolio
0.14%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
657Shares Held
208MCall Options Held
3.83MPut Options Held
4.26M-
Jpmorgan Chase & CO New York, NY23MShares$4.45 Billion0.22% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y920.5MShares$3.95 Billion89.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.9MShares$3.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.76 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA7.55MShares$1.46 Billion0.18% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $26.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...